Skip to main content

Table 4 APOE epsilon polymorphism and cardiometabolic risk

From: Association study of APOE gene polymorphisms with diabetes and the main cardiometabolic risk factors, in the Algerian population

APOE ε ISOR
  APOE3 APOE2 APOE4
T2D
No/yes 455/58 52/6 116/12
OR (95% CI) 1.00 (ref) 0.87 (0.34–2.22) 0.84 (0.42–1.68)
p   0.77 0.63
Obesity
No/yes 414/111 47/20 115/22
OR (95% CI) 1.00 (ref) 1.88 (1.01–3.51) 0.80 (0.48–1.37)
p   0.04 0.41
MetS
No/yes 424/96 48/18 108/28
OR (95% CI) 1.00 (ref) 1.74 (0.92–3.32) 1.29 (0.78–2.14)
p   0.09 0.33
HBP
No/yes 413/112 54/13 110/27
OR (95% CI) 1.00 (ref) 1.18 (0.63–2.20) 0.97 (0.60–1.59)
p   0.60 0.92
  1. T2D type 2 diabetes, MetS metabolic syndrome, HBP high blood pressure. p values were adjusted for age, gender, physical activity, and smoking status. Significant p values are indicated in italics with an asterisk